Opinion

Video

Biomarker Use in Patients on Active Surveillance

The panel explores the role of biomarkers in monitoring disease progression for prostate cancer patients on active surveillance, discussing how these tests aid in detecting changes that may warrant intervention.

Video content above is prompted by the following question:

  • For patients on active surveillance, how do you use biomarkers?
Related Videos
Betty Wang, MD, discusses studies from the 2025 EAU meeting
Dr Louise Kostos answers a question during a Zoom video interview
Dr Louise Kostos answers a question during a Zoom video interview
Dr Louise Kostos answers a question during a Zoom video interview
Related Content
© 2025 MJH Life Sciences

All rights reserved.